VILTOLARSEN

VILTOLARSEN was reported 170 times

VILTOLARSEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYSTATIN C ABNORMAL 1 0.0909
1 DUCHENNE MUSCULAR DYSTROPHY 2 0.0215
2 CYSTATIN C INCREASED 2 0.0156
3 CATHETER SITE CELLULITIS 1 0.0034
4 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
5 ANTIBODY TEST ABNORMAL 2 0.0028
6 HAND-FOOT-AND-MOUTH DISEASE 2 0.0024
7 CONGESTIVE HEPATOPATHY 1 0.0022
8 BODY HEIGHT INCREASED 1 0.0020
9 CATHETER SITE INFLAMMATION 1 0.0018
10 CROUP INFECTIOUS 1 0.0013
11 SKIN BACTERIAL INFECTION 1 0.0012
12 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
13 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
14 HYPOCHROMIC ANAEMIA 1 0.0010
15 THYROID HORMONES INCREASED 1 0.0010
16 GROIN ABSCESS 1 0.0008
17 CATHETER SITE INFECTION 3 0.0008
18 PROTEIN TOTAL ABNORMAL 1 0.0008
19 MENINGITIS VIRAL 1 0.0007
20 WHEELCHAIR USER 3 0.0007
21 SKIN STRIAE 1 0.0007
22 COSTOCHONDRITIS 1 0.0006
23 SHOULDER FRACTURE 1 0.0006
24 SPINAL DEFORMITY 1 0.0006
25 INFUSION SITE DISCHARGE 1 0.0006
26 BEHAVIOUR DISORDER 3 0.0006
27 CATHETER PLACEMENT 1 0.0005
28 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
29 DEVICE RELATED SEPSIS 1 0.0005
30 INFUSION SITE SWELLING 3 0.0005
31 SLEEP DEFICIT 1 0.0005
32 INFUSION SITE BRUISING 1 0.0005
33 INFUSION SITE INFECTION 1 0.0004
34 TIBIA FRACTURE 2 0.0004
35 SARS-COV-2 TEST POSITIVE 5 0.0004
36 FIBULA FRACTURE 1 0.0003
37 INFUSION SITE REACTION 1 0.0003
38 URINE ANALYSIS ABNORMAL 1 0.0003
39 CENTRAL VENOUS CATHETERISATION 1 0.0003
40 INFUSION SITE EXTRAVASATION 2 0.0003
41 FRUSTRATION TOLERANCE DECREASED 2 0.0002
42 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
43 DISEASE COMPLICATION 1 0.0002
44 PROTEIN URINE PRESENT 1 0.0002
45 COMPRESSION FRACTURE 1 0.0002
46 STREPTOCOCCAL INFECTION 1 0.0002
47 ENTEROCOLITIS 1 0.0002
48 HYPERTRIGLYCERIDAEMIA 1 0.0002
49 BRADYKINESIA 1 0.0002
50 OLIGURIA 1 0.0002
51 PROTEINURIA 3 0.0002
52 INFUSION SITE PAIN 2 0.0002
53 RIGHT VENTRICULAR FAILURE 1 0.0001
54 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
55 DEVICE RELATED INFECTION 2 0.0001
56 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
57 BLOOD DISORDER 1 0.0001
58 ANGER 4 0.0001
59 GASTROENTERITIS VIRAL 2 0.0001
60 INCREASED TENDENCY TO BRUISE 1 0.0001
61 ILLNESS 11 0.0001
62 FLANK PAIN 1 0.0001
63 BLADDER DISORDER 1 0.0001
64 TOOTH ABSCESS 1 0.0001
65 SLUGGISHNESS 1 0.0001
66 VIRAL INFECTION 3 0.0001
67 GAIT INABILITY 3 0.0001
68 DERMATITIS CONTACT 1 0.0001
69 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
70 ADRENAL INSUFFICIENCY 1 0.0001
71 INJECTION SITE EXTRAVASATION 1 0.0001
72 PNEUMONIA ASPIRATION 2 0.0001
73 AGGRESSION 4 0.0001
74 PALLOR 2 0.0001
75 HYPOKINESIA 1 0.0001
76 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
77 LABORATORY TEST ABNORMAL 2 0.0001
78 FEMUR FRACTURE 2 0.0001
79 PNEUMOTHORAX 1 0.0001
80 MOOD SWINGS 2 0.0001
81 MULTIPLE FRACTURES 1 0.0001
82 PYREXIA 21 0.0001
83 VENTRICULAR TACHYCARDIA 1 0.0001
84 THIRST 1 0.0001
85 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
86 FRACTURE 1 0.0001
87 BLOOD URINE PRESENT 1 0.0001
88 POST PROCEDURAL COMPLICATION 1 0.0001
89 LOWER LIMB FRACTURE 1 0.0001
90 ERUCTATION 1 0.0001
91 ABNORMAL BEHAVIOUR 2 0.0001
92 UPPER LIMB FRACTURE 1 0.0001
93 FEEDING DISORDER 1 0.0000
94 BODY TEMPERATURE INCREASED 1 0.0000
95 RETCHING 1 0.0000
96 INFLUENZA 5 0.0000
97 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
98 LOCALISED INFECTION 1 0.0000
99 WEIGHT INCREASED 9 0.0000
100 INFLAMMATION 2 0.0000
101 EAR INFECTION 1 0.0000
102 HAEMATOCHEZIA 2 0.0000
103 INTENTIONAL DOSE OMISSION 1 0.0000
104 LETHARGY 2 0.0000
105 COVID-19 6 0.0000
106 IRRITABILITY 2 0.0000
107 ADVERSE EVENT 3 0.0000
108 EMOTIONAL DISORDER 1 0.0000
109 OROPHARYNGEAL PAIN 3 0.0000
110 LIMB DISCOMFORT 1 0.0000
111 HEART RATE INCREASED 3 0.0000
112 VOMITING 14 0.0000
113 CRYING 1 0.0000
114 INJECTION SITE MASS 1 0.0000
115 HEPATIC FUNCTION ABNORMAL 1 0.0000
116 PNEUMONIA 8 0.0000
117 ABDOMINAL DISCOMFORT 4 0.0000
118 DEVICE DISLOCATION 1 0.0000
119 MENTAL DISORDER 1 0.0000
120 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
121 NEPHROLITHIASIS 1 0.0000
122 HYPOKALAEMIA 1 0.0000
123 CHEST PAIN 4 0.0000
124 RENAL DISORDER 1 0.0000
125 COUGH 6 0.0000
126 SWELLING 2 0.0000
127 PRODUCTIVE COUGH 1 0.0000
128 PRODUCT DOSE OMISSION ISSUE 6 0.0000
129 CELLULITIS 1 0.0000
130 DEPRESSED MOOD 1 0.0000
131 PLATELET COUNT DECREASED 2 0.0000
132 OEDEMA 1 0.0000
133 ANAPHYLACTIC REACTION 1 0.0000
134 MEDICATION ERROR 1 0.0000
135 NECK PAIN 1 0.0000
136 THROMBOCYTOPENIA 2 0.0000
137 BLISTER 1 0.0000
138 MYALGIA 3 0.0000
139 NASAL CONGESTION 1 0.0000
140 DISEASE PROGRESSION 2 0.0000
141 NASOPHARYNGITIS 3 0.0000
142 MALAISE 7 0.0000
143 RHINORRHOEA 1 0.0000
144 FALL 5 0.0000
145 INJECTION SITE PRURITUS 1 0.0000
146 HEPATIC ENZYME INCREASED 1 0.0000
147 MOBILITY DECREASED 1 0.0000
148 RESPIRATORY FAILURE 1 0.0000
149 ACNE 1 0.0000
150 CARDIAC FAILURE 1 0.0000
151 URTICARIA 2 0.0000
152 RENAL IMPAIRMENT 1 0.0000
153 GASTROINTESTINAL DISORDER 1 0.0000
154 DEVICE ISSUE 1 0.0000
155 ANXIETY 3 0.0000
156 CONTUSION 1 0.0000
157 HYPOTENSION 2 0.0000
158 SINUSITIS 1 0.0000
159 ERYTHEMA 2 0.0000
160 ABDOMINAL PAIN UPPER 2 0.0000
161 CONSTIPATION 2 0.0000
162 SEPSIS 1 0.0000
163 SEIZURE 1 0.0000
164 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
165 ABDOMINAL PAIN 2 0.0000
166 CHILLS 1 0.0000
167 OEDEMA PERIPHERAL 1 0.0000
168 INJECTION SITE ERYTHEMA 1 0.0000
169 DIARRHOEA 5 0.0000
170 DEHYDRATION 1 0.0000
171 VISION BLURRED 1 0.0000
172 WEIGHT DECREASED 2 0.0000
173 BLOOD PRESSURE INCREASED 1 0.0000
174 HOSPITALISATION 1 0.0000
175 PERIPHERAL SWELLING 1 0.0000
176 OFF LABEL USE 5 0.0000
177 NO ADVERSE EVENT 1 0.0000
178 DYSPNOEA 3 0.0000
179 ANAEMIA 1 0.0000
180 GAIT DISTURBANCE 1 0.0000
181 NAUSEA 4 0.0000
182 SOMNOLENCE 1 0.0000
183 ARTHRALGIA 2 0.0000
184 HEADACHE 3 0.0000
185 INCORRECT DOSE ADMINISTERED 1 0.0000
186 DECREASED APPETITE 1 0.0000
187 BACK PAIN 1 0.0000
188 FATIGUE 3 0.0000
189 INSOMNIA 1 0.0000
190 DEATH 3 0.0000
191 PAIN IN EXTREMITY 1 0.0000
192 CONDITION AGGRAVATED 1 0.0000
193 DIZZINESS 1 0.0000
194 PAIN 1 0.0000
195 DRUG INEFFECTIVE 1 0.0000